{
    "clinical_study": {
        "@rank": "85639", 
        "arm_group": [
            {
                "arm_group_label": "dapsone gel - verum", 
                "arm_group_type": "Active Comparator", 
                "description": "dapsone gel - verum"
            }, 
            {
                "arm_group_label": "dapsone gel - vehicle only", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Principal aim of this study is to assess whether a combination of topical dapsone and\n      clobetasol as a topical steroid is superior to clobetasol alone as treatment of prurigo\n      nodularis or lichen simplex chronicus in a side to side comparison. The study is primarily\n      exploratory and essentially meant to inform the sponsor whether further development of a\n      combination treatment formulation is warranted"
        }, 
        "brief_title": "Dapsone Prurigo Study", 
        "completion_date": {
            "#text": "November 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Lichen Simples Chronicus and Prurigo", 
        "condition_browse": {
            "mesh_term": [
                "Prurigo", 
                "Neurodermatitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022 Active prurigo nodularis or lichen simplex chronicus - diagnosed by clinical exam\n\n               -  For lichen simplex chronicus patients: Severity of maximum pruritus in the last\n                  24 hrs at least 5 out of 10 on a visual analogue scale.\n\n               -  For prurigo nodularis patients: Excoriations or signs of other scratch related\n                  activity at presentation to demonstrate active disease\n\n               -  Symmetrical disease/excoriations allowing for a side-by-side comparison (eg,\n                  bilateral lichen simplex chronicus or bilateral prurigo nodularis) - genitals,\n                  face, axillae or neck cannot be used for side-to-side comparison\n\n               -  Willing to refrain from use of all other topical medications in the treatment\n                  areas.\n\n               -  Able and willing to provide written informed consent\n\n               -  Willing and able to understand and comply with the requirements of the study,\n                  apply the treatment combinations as instructs, attend required study visits,\n                  comply with study prohibitions and able to complete the study.\n\n               -  Male or non-preganant, non-lactating female between 18 and 75 years of age,\n                  inclusive\n\n               -  For females of child-bearing potential, willing to use adequate birth control\n                  during the study conduct\n\n        Exclusion Criteria:\n\n          -  \u2022 History of non-compliance with follow up visits\n\n               -  Should we exclude failure to certain treatments as an exclusion criterion?\n                  Patients who failed oral dapsone should be excluded\n\n               -  Presence of any skin condition on the treatment areas that would interfere with\n                  the diagnosis or assessment of active lichen simplex chronicus and/or prurigo\n                  nodularis (eg, rosacea, dermatitis, psoriasis, squamous cell carcinoma, eczema,\n                  acneform eruptions caused by medications, steroid acne, steroid folliculitis or\n                  bacterial folliculitis)\n\n               -  Excessive hair in the treatment area that would interfere with diagnosis or\n                  assessment of lichen simplex chronicus and/or prurigo nodularis\n\n               -  History of hypersensitivity or allergy to topical steroids, dapsone, or any\n                  other treatment product components\n\n               -  Use of tanning booths, sunbathing or excessive exposure to the sun during the\n                  study\n\n               -  Consumes excessive amount of alcohol, abuses drugs, or has any condition that\n                  would compromise compliance with this protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01870050", 
            "org_study_id": "Cookderm 01"
        }, 
        "intervention": {
            "arm_group_label": "dapsone gel - verum", 
            "intervention_name": "Dapsone gel - verum", 
            "intervention_type": "Drug", 
            "other_name": "aczone gel"
        }, 
        "intervention_browse": {
            "mesh_term": "Dapsone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "lichen simplex chronicus", 
            "prurigo"
        ], 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "contact": {
                "email": "jalbrecht@cookcountyhhs.org", 
                "last_name": "Joerg Albrecht, MD", 
                "phone": "312-864-4480"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60612"
                }, 
                "name": "J H Stroger Hospital of Cook County"
            }, 
            "investigator": [
                {
                    "last_name": "Joerg Albrecht", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Warren Piette, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double-blind, Randomized, Parallel-group, Side-by-side Single-center Study Comparing a Topical Steroid / Vehicle Combination to a Topical Steroid / Topical Dapsone Combination in Patients With Lichen Simplex Chronicus and/or Prurigo Nodularis", 
        "overall_contact": {
            "email": "jalbrecht@cookcountyhhs.org", 
            "last_name": "Joerg Albrecht, MD", 
            "phone": "3128644480"
        }, 
        "overall_official": {
            "affiliation": "J.H.Stroger Hospital of Cook County", 
            "last_name": "Joerg Albrecht, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pruritus based on visual analogue scale in side to side comparison", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01870050"
        }, 
        "responsible_party": {
            "investigator_affiliation": "John H. Stroger Hospital", 
            "investigator_full_name": "Joerg Albrecht", 
            "investigator_title": "Attending Physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "5 D itch scale in side to side comparison", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "source": "John H. Stroger Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "John H. Stroger Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}